JP2023509443A5 - - Google Patents

Info

Publication number
JP2023509443A5
JP2023509443A5 JP2022540917A JP2022540917A JP2023509443A5 JP 2023509443 A5 JP2023509443 A5 JP 2023509443A5 JP 2022540917 A JP2022540917 A JP 2022540917A JP 2022540917 A JP2022540917 A JP 2022540917A JP 2023509443 A5 JP2023509443 A5 JP 2023509443A5
Authority
JP
Japan
Prior art keywords
acid sequence
optionally
amino acid
promoter
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022540917A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023509443A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/067664 external-priority patent/WO2021138559A1/en
Publication of JP2023509443A publication Critical patent/JP2023509443A/ja
Publication of JP2023509443A5 publication Critical patent/JP2023509443A5/ja
Pending legal-status Critical Current

Links

JP2022540917A 2019-12-31 2020-12-31 改善されたaav-abcd1コンストラクトならびに副腎白質ジストロフィー(ald)および/または副腎脊髄ニューロパチー(amn)の処置または予防のための使用 Pending JP2023509443A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962955667P 2019-12-31 2019-12-31
US62/955,667 2019-12-31
PCT/US2020/067664 WO2021138559A1 (en) 2019-12-31 2020-12-31 Improved aav-abcd1 constructs and use for treatment or prevention of adrenoleukodystrophy (ald) and/or adrenomyeloneuropathy (amn)

Publications (2)

Publication Number Publication Date
JP2023509443A JP2023509443A (ja) 2023-03-08
JP2023509443A5 true JP2023509443A5 (cg-RX-API-DMAC7.html) 2023-07-05

Family

ID=76686949

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022540917A Pending JP2023509443A (ja) 2019-12-31 2020-12-31 改善されたaav-abcd1コンストラクトならびに副腎白質ジストロフィー(ald)および/または副腎脊髄ニューロパチー(amn)の処置または予防のための使用

Country Status (11)

Country Link
US (2) US11779655B2 (cg-RX-API-DMAC7.html)
EP (1) EP4085143B1 (cg-RX-API-DMAC7.html)
JP (1) JP2023509443A (cg-RX-API-DMAC7.html)
KR (1) KR20220128632A (cg-RX-API-DMAC7.html)
CN (1) CN116096904A (cg-RX-API-DMAC7.html)
AU (1) AU2020416291A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022013027A2 (cg-RX-API-DMAC7.html)
CA (1) CA3166374A1 (cg-RX-API-DMAC7.html)
IL (1) IL294278A (cg-RX-API-DMAC7.html)
MX (1) MX2022008201A (cg-RX-API-DMAC7.html)
WO (1) WO2021138559A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3228344A1 (en) * 2021-08-06 2023-02-09 Wuhan Neurophth Biotechnology Limited Company Composition and method for treating leber's hereditary optic neuropathy caused by nd4 mutation
US20240229067A9 (en) * 2022-05-12 2024-07-11 AAVnerGene Inc. Compositions and methods for recombinant parvovirus production
WO2023220502A1 (en) * 2022-05-12 2023-11-16 AAVnerGene Inc. Compositions and methods for recombinant parvovirus production
EP4536862A1 (en) * 2022-06-09 2025-04-16 Wisconsin Alumni Research Foundation Generation of next generation recombinant aav gene therapy vectors that adopt 3d conformation
AU2024315073A1 (en) * 2023-07-28 2026-01-22 Regeneron Pharmaceuticals, Inc. Use of bgh-sv40l tandem polya to enhance transgene expression during unidirectional gene insertion

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103589692B (zh) 2001-11-13 2018-07-24 宾夕法尼亚大学托管会 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
DK2359869T3 (en) 2001-12-17 2019-04-15 Univ Pennsylvania Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
EP1668143B1 (en) 2003-09-30 2013-03-20 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
DE23193606T1 (de) 2005-04-07 2024-02-15 The Trustees Of The University Of Pennsylvania Verfahren zur erhöhung der funktion eines aav-vektors
US7588772B2 (en) 2006-03-30 2009-09-15 Board Of Trustees Of The Leland Stamford Junior University AAV capsid library and AAV capsid proteins
AU2009273239B2 (en) * 2008-07-23 2015-07-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel regulatory elements
JP6091435B2 (ja) * 2011-02-22 2017-03-08 カリフォルニア インスティチュート オブ テクノロジー アデノ随伴ウイルス(aav)ベクターを用いたタンパク質の送達
DK2717922T3 (en) * 2011-06-10 2019-01-07 Bluebird Bio Inc GENERATIVE VECTORS FOR ADDRENOLEUCODYSTROPHY AND ADDRENOMYELONE EUROPE
US9163259B2 (en) * 2012-05-04 2015-10-20 Novartis Ag Viral vectors for the treatment of retinal dystrophy
EP2940131B1 (en) * 2012-12-25 2019-02-20 Takara Bio Inc. Aav variant
WO2015153889A2 (en) * 2014-04-02 2015-10-08 University Of Florida Research Foundation, Incorporated Materials and methods for the treatment of latent viral infection
EP3270960A4 (en) * 2015-03-20 2018-08-08 Bluebird Bio, Inc. Vector formulations
EP3285788B1 (en) * 2015-04-23 2024-12-18 University of Massachusetts Modulation of aav vector transgene expression
PL3370705T3 (pl) * 2015-11-05 2022-08-01 The General Hospital Corporation Dooponowe dostarczanie sekwencji kwasów nukleinowych do kodowania abcd1 w leczeniu adrenomieloneuropatii
HRP20231451T1 (hr) * 2016-02-05 2024-03-01 Emory University Ubrizgavanje jednolančanog ili samo-komplementarnog adeno-povezanog virusa 9 u cerebrospinalnu tekućinu
WO2017137585A1 (en) * 2016-02-12 2017-08-17 Combigene Ab Vector
CN107287239B (zh) * 2016-04-11 2020-09-22 厦门继景生物技术有限责任公司 一种用于视网膜色素变性的基因治疗载体及药物
ES2982489T3 (es) * 2016-08-19 2024-10-16 Univ Florida Composiciones para el tratamiento de afecciones que utilizan virus adeno-asociados recombinantes autocomplementarios
CA3050690A1 (en) * 2017-01-17 2018-07-26 Dana-Farber Cancer Institute, Inc. Compositions and methods for diagnosing and treating peroxisomal diseases
CN110650624A (zh) * 2017-03-10 2020-01-03 威斯康星州医药大学股份有限公司 用于视网膜疾病的核糖开关调节的基因治疗
US20200377887A1 (en) * 2017-09-22 2020-12-03 Voyager Therapeutics, Inc. Compositions and methods of treating huntington's disease
US12201657B2 (en) * 2017-10-18 2025-01-21 City Of Hope Adeno-associated virus compositions for restoring HBB gene function and methods of use thereof
GB201817470D0 (en) * 2018-10-26 2018-12-12 Univ Oxford Innovation Ltd Gene therapy

Similar Documents

Publication Publication Date Title
Büeler Adeno-associated viral vectors for gene transfer and gene therapy
US6365403B1 (en) High-efficiency AAV helper functions
JP2022549380A5 (cg-RX-API-DMAC7.html)
JP2022535749A5 (cg-RX-API-DMAC7.html)
AU2018207259A1 (en) Polynucleotides and vectors for the expression of transgenes
US12077772B2 (en) Transgene cassettes, AAV vectors and AAV viral vectors for the expression of human codon-optimized SLC6A1
AU2001279198A1 (en) Helper functions for recombinant vector production
WO2004020600A2 (en) Modified aav
WO2001036623A2 (en) Ecdysone-inducible adeno-associated virus expression vectors
WO2020142714A1 (en) Aav expression cassette and aav vectors comprising the same
AU2023378899A1 (en) Gene therapy for frontotemporal dementia
WO2021113634A1 (en) Transgene cassettes designed to express a human mecp2 gene
CN120548368A (zh) 用于正确包装重复元件的腺相关病毒载体
JP2023542241A5 (cg-RX-API-DMAC7.html)
AU2021255934A1 (en) Compositions and methods for treatment of neurological disorders
US20260131024A1 (en) Gene therapy for prader willi syndrome
JP2025515030A5 (cg-RX-API-DMAC7.html)
WO2023056367A1 (en) Slc13a5 gene therapy vectors and uses thereof
WO2023111106A1 (en) Fukutin related protein gene transfer increase using modified itr sequences
WO2022169861A2 (en) Gene therapy for angelman syndrome
CN117836312A (zh) 分离的修饰的aav9衣壳蛋白vp1
US12480098B1 (en) Adeno-associated virus variant
WO2025162449A1 (en) Compositions and methods for the treatment of heart disease
CN118955653A (zh) 腺相关病毒衣壳蛋白的突变体、编码其的核酸及应用
HK40128602A (en) Improved recombinant polyadenylation signal sequences and use thereof